|1.||Oszczapowicz, Janusz: 2 articles (03/2007 - 05/2006)|
|2.||Opolski, Adam: 2 articles (03/2007 - 05/2006)|
|3.||Oszczapowicz, Irena: 2 articles (03/2007 - 05/2006)|
|4.||Wietrzyk, Joanna: 2 articles (03/2007 - 05/2006)|
|5.||Wasowska-Lukawska, Malgorzata: 1 article (03/2007)|
|6.||Wasowska, Malgorzata: 1 article (05/2006)|
05/01/2006 - "The obtained results indicated that introduction of the amidino group into the daunosamine moiety of anthracycline molecules appears to overcome the drug resistance of cancer cells."
03/01/2007 - "In the search for new derivatives of daunorubicin with high activity and/or the ability to overcome the drug resistance barrier of cancer cells, some new analogs of amidino-daunorubicin, containing the chiral substituent in the formamidine group (-N=CH-N<) at the C-3' position of daunosamine moiety, have been synthesized. "
|2.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/01/1990 - "The intramolecular combination of 9-alkyl substitution in the anthracycline A-ring plus incorporation of the amino group of the daunosamine sugar within a morpholinyl ring led to the retention of almost complete activity against P-glycoprotein positive, multidrug resistant variants of a mouse mammary tumour line and a human small cell lung cancer line. "